Abstract
A stroke or Cerebrovascular Accident
(CVA) is an urgent medical condition marked by an abrupt impairment of the
cerebral vasculature or perfusion. The main cause of ischemic CVA is elevated
blood pressure. Carotid dissection, coagulation issues and illegal drug use are
major contributors in younger people. For CVA patients to have a better
prognosis, they must receive an early diagnosis and effective treatment. With
15 million cases worldwide, Sub-Saharan Africa has the highest incidence rates,
with up to 14 strokes per 1000 people. CVA causes 5.5 million deaths annually,
with over 50% of survivors permanently incapacitated. The primary cause of high
morbidity and mortality from CVA and other neurological disorders in developing
nations is the lack of human resources. Neurologists, neurosurgeons and
psychiatrists with advanced training are in short supply in developing
countries. In addition, most stroke drugs, including tissue plasminogen
activator (t-PA), are too costly for most patients and underdeveloped
countries. The primary means of addressing the issue of the increasing number
of CVAs is by implementing stroke prevention strategies, identifying
individuals at increased risk and utilizing multidisciplinary stroke therapy.
This approach, coupled with providing neuroimaging services and equipment to
developing countries, can help curb these challenges.
Keywords: Cerebrovascular accident, Stroke, Cerebral, Neuroimaging
1. Introduction
A stroke, sometimes referred to as a
cerebrovascular accident, is an urgent medical condition marked by an abrupt
disruption of the cerebral vasculature or perfusion. Hypertension is the main
cause of ischemic stroke; however, coagulation problems, carotid dissection and
illegal drug use are also major causes of ischemic stroke in younger
individuals1. An immediate
diagnosis and prompt management are necessary to improve the prognosis of
stroke patients. This activity examines the etiology, epidemiology, diagnosis
and management of cerebrovascular disease as well as the challenges facing the
diagnosis and management of the condition. Thus, to avoid or significantly
reduce morbidity and mortality, it is imperative to identify and treat stroke
early. During the acute phase, a quick history and examination were conducted. The
saying “time is brain” makes it imperative not to waste any of it. Because
acute stroke treatment is evolving rapidly, patients may require Intravenous tissue
Plasminogen Activator (IV tPA) for up to 4.5 hours or mechanical thrombectomy
for up to six hours1.
Stroke is linked to significant
economic expenses and is a primary cause of disability, dementia and mortality
globally. One stroke will occur in the lifespan of an average of one in four people
worldwide2. This statistic is
quite alarming, thus making it a common neurological problem. However, the
availability of more acute stroke treatments and better inpatient care in
high-income countries are likely the main reasons why age-standardized stroke
death rates decreased significantly globally between 1990 and 2016. In
contrast, the decrease in incidence was less severe in Africa3.
In Africa, stroke was comparatively
rare less than a century ago. However, in terms of Disability-Adjusted Life
Years (DALYs) in northern, central, western, eastern and southern Africa,
meningitis and migraine have ranked highest in recent systematic assessments
conducted by investigators of the global burden of neurological diseases4,5. Africa currently has some of the
highest global stroke burden indices5. Numerous causes spanning the
lifespan are to blame for Africa's rising stroke burden. Significant
contributing variables include dietary changes, population aging, increased
exposure to indoor and outdoor particle air pollution and undernutrition during
pregnancy and early life, which is associated with increased cardiometabolic
risk factors in midlife6.
Over the past ten years, stroke
medicine in Africa has evolved; we now have a better grasp of
population-attributable risk and the effect sizes of both established and new
risk factors. African communities can now access more knowledge on the etiology
of strokes as well as the pathophysiological types and subtypes of these
diseases6. This includes a better
comprehension of strokes brought on by HIV/AIDS infection and sickle cell
illness6.
Notwithstanding these developments,
there are still a lot of unanswered questions regarding stroke in Africa as
well as stroke treatment, practice and policy in the region. Establishing
effective systems for stroke prevention, treatment and rehabilitation remains a
challenge in many African countries6.
2. Epidemiology
Strokes affect 15 million people
annually worldwide; of these, 5 million die and another 5 million become
permanently disabled, creating a burden on families and society. Strokes are
rare in people under 40 and the main cause is typically excessive blood
pressure. On the other hand, stroke occurs in 8% of children with sickle cell
disease7. Due to up to 40% of
stroke deaths happening within a month, up to 316 strokes per 100,000 people
and a frequency of up to 14 strokes per 1000 people, Sub-Saharan Africa seems
to have the highest age-standardized stroke incidence rates in the world8. With an age cutoff of fewer than 50
years, young people's strokes make up 10% to 14% of all ischemic strokes in
high-income countries9.
The first community-based research
of stroke incidence in Africa was conducted in the southwest Nigerian city of
Ibadan between 1973 and 1975, using data from the Ibadan Stroke Registry. It
was stated that the annual crude incidence rate was 26 per 100,000 individuals10. Similar studies conducted in Lagos and
Akure, Southwest Nigeria, in 2007 and 2010 found that the annual crude
incidence rates were 25 per 100,00011
and 61 per 100,000, respectively12.
The findings of population-based studies
indicate that stroke-related mortality is significant in Africa; estimates of
the percentage of stroke-related fatalities to total deaths range from 5.5% to
11%13. In Agincourt, South
Africa, research conducted from 1992 to 1995 assessed the crude stroke mortality
rate for adults over the age of 35 to be 127 per 100,000; however, a 2016 study
conducted at the same location showed a mortality rate of 114 per 100,00014.
Using data from the GBD study, Sub-Saharan Africa saw the least reduction in stroke-associated disability-adjusted life years (DALYs) between 1990 and 20164. 80% of all strokes, 77% of all stroke survivors, 87% of all stroke-related fatalities and 89% of all stroke-related Disability-Adjusted Living Years (DALYs) occur in LMICs (Table 1), including those in Africa, according to the same data15.
Table 1: Studies of stroke incidence in selected African countries.
|
Country/region |
Study period |
Type of Study |
Neuroimaging
confirmation |
Stroke subtype |
Crude annual incidence
rate |
Ref |
|
Incidence; annual range
25-260 per 100,000 from 1973 to 2013 |
||||||
|
Nigeria, Ibadan |
1973-1975 |
Community |
No |
Yes |
26 |
10 |
|
Libya, Benghazi |
1983-1984 |
Hospital |
Yes |
Yes |
63 |
16 |
|
South Africa, Pretoria |
1984-1985 |
Hospital |
Yes |
Yes |
101 |
17 |
|
Egypt, Sohag |
1992-1993 |
Community |
Yes |
Yes |
180 |
18 |
|
Mozambique, Maputo |
2005-2006 |
Hospital |
Yes |
Yes |
149 |
19 |
|
Egypt, Al-Kharga |
2005-2008 |
Community |
Yes |
No |
260 |
12 |
|
Nigeria, Akure |
2010-2011 |
Mixed |
Yes |
Yes |
61 |
20 |
3. Implication of
Stroke
3.1. To the individual
The effects of stroke are severe and
typically affect more people than just the patient. The annual incidence of
stroke is increasing in the general population, even if stroke-related deaths
are declining. Acute stroke is often the beginning of a lifelong battle with
physical damage and ensuing disability for many stroke survivors and their
families21. Over time, several
less well-known medical, musculoskeletal and behavioral issues exacerbate the
initial clinical effects of stroke21.
The repercussions of a stroke may
include a range of problems associated with extended hospitalization and
immobilization, as well as deteriorating neurological status due to hemorrhagic
conversion or stroke extension. A multicenter study22 found that the most frequent complications after the
acute phase of stroke were recurrent strokes (9%), epileptic seizures (3%),
urinary tract infections (24%), pneumonia (22%), pressure sores (21%), deep
vein thrombosis (2%), pulmonary emboli (1%), depression (16%) and anxiety (14%).
3.2. To the family
Families may experience significant
stress in the initial days and weeks following a stroke as they process the
shock of what happened. Most families are left feeling uncertain about the
diagnosis and what comes next because strokes typically happen quickly. When a
couple shifts from a union that is based on mutual support to one that is
focused on caregiving, intimacy may be lost and adult children may face
particular challenges in juggling their personal and parental responsibilities23.
Despite the fact that stroke's
effects on family relationships have gotten less attention, research by Clark et al24. allows for certain
conclusions to be drawn. Using a structured interview schedule, Clark et al24. discovered that 32% of
families had inadequate family functioning and 66% of families had severe
conflict. These findings indicate that there was significant family dysfunction
in the first nine months following stroke. Similarly, 35% of caregivers in a population-based
study of 84 families in Australia reported negative effects on family ties for
a variety of reasons, such as miscommunication and the transfer of resentment
regarding the stroke to other people.
3.3.
Public health burden of stroke
With an estimated 5.5 million deaths
per year, stroke is one of the most common causes of death globally25. The significant morbidity of stroke
causes up to 50% of survivors to be permanently incapacitated, adding to the
disease's burden in addition to its high mortality. Based on the most recent
data available on the worldwide burden of illness related to stroke, there were
10.3 million new cases of stroke, 6.5 million fatalities, 113 million DALYs
caused by stroke and approximately 25.7 million stroke survivors in 2013.
Consequently, stroke is a condition that has major implications for both public
health, the economy and society26.
There are currently 4.85 million
stroke deaths and 91.4 million Disability-Adjusted Life Years (DALYs) each year
in developing countries, compared to 1.6 million deaths and 21.5 million DALYs
in high-income countries, suggesting that the burden of stroke is shifting to
these countries. In North Asia, the South Pacific, eastern Europe and central
Africa, the stroke load is much higher. Because of ongoing demographic trends
including population aging and changes in health care in these countries, the
developing world is expected to have a much higher stroke rate in the ensuing
decades26.
According to a study conducted in Benin, the developing world bears the burden of the stroke epidemic; the most commonly reported stroke risk factor was hypertension (34.5%), while the most commonly reported stroke warning signals were paralysis and hemiplegia (34.4%). Similar claims have been made about Ghana and Nigeria's insufficient awareness of stroke risk factors and warning indicators (Figure 1). Nonetheless, 91.7% of university employees in Nigeria were able to identify hypertension, demonstrating their outstanding knowledge of stroke risk factors27.
Figure 1: A map showing the global burden of stroke and images of the global, regional and national burdens of stroke and its risk factors from 1990-20193.
4. Challenges in the Diagnosis and Management of Stroke
The scarcity of resources in
developing countries is the primary cause of the excess morbidity and mortality
that arise from stroke and other neurological illnesses. The first in line is
the human resource deficit. There is a shortage of highly qualified clinical
neuroscience personnel in developing nations (neurologists, neurosurgeons and
psychiatrists)28.
Another issue is the dearth of
diagnostic resources (instrumentation). Advanced diagnostic tools such as
cerebral angiography, ECG, CT scan, MRI and carotid duplex imaging are lacking.
The two most crucial diagnostic methods are standard clinical examination and
interviewing, which are used for indications of abnormal neurologic function.
If these methods are not used correctly, the treatment plan may be affected.
However, effective management and diagnosis frequently necessitate the use of
diagnostic tools, which are typically found in clinics and hospitals with
adequate equipment26.
Furthermore, the majority of stroke medications, such as tissue plasminogen activator (t-PA), are too expensive for the majority of patients and developing nations. Other infrastructure, such as referral centers and systems for maintaining medical records, is extremely subpar in underdeveloped nations28.
5. The Way Forward
Stroke prevention is the main
strategy for tackling the problem of the rising number of strokes. The World
Health Organization advises combining high-risk and population-wide efforts to
prevent stroke and other cardiovascular diseases (CVDs). A crucial part of the
high-risk prevention plan is figuring out the absolute risk of CVD over the
next five or 10 years, since this helps identify people who are more likely to
suffer acute CVD. Population-wide prevention techniques focus on a variety of
lifestyle and behavioral risk factors. This approach is essential because the
incidence of stroke and CVD in the general population can be considerably
reduced with even modest changes in the distribution of risk factors. Other key
stroke prevention strategies include community-based education initiatives and
digital health technologies29.
Acute treatment, rehabilitation,
disease prevention and health promotion-the four stroke quadrant domains-face
numerous challenges in the African stroke care system. Nevertheless, there are
several workable solutions to these obstacles. First, regulations that direct
regular examinations and risk factor identification should be put into place.
By developing a framework for frequently monitoring and evaluating stroke
(including burden and risk factors) and health services at the national level,
epidemiological surveillance can be improved. This paradigm might combine
surveillance technology with community-based surveys. Second, implementing
integrated individual and population-wide preventative methods may limit
exposure to and enhance management of modifiable risk factors6. Third, acute stroke treatment can be
enhanced by skillfully organizing its services, including staff development and
capacity growth. Finally, expanding access to multidisciplinary care-including
methods such as task sharing-can enhance poststroke rehabilitation offerings6.
The use of neuroimaging will rise
and in-hospital mortality will drop significantly as a result of
multidisciplinary stroke care. In many African contexts, neuroimaging services
(MRI or CT) are not readily available, reasonably priced or easily accessible,
while being necessary for an accurate diagnosis of stroke. The supply of
neurological institutes, personnel training and retraining and these services
and equipment to developing nations will therefore aid in reducing some of
these issues9.
6. Future Implication
It is important to know that
programs for public awareness are crucial. In the past, a patient's stroke was
not officially diagnosed until at least 24 hours had passed. This results in
patient apathy and prolonged inaction on the part of doctors. It is crucial to
stress that defining stroke as a 24-hour period is no longer appropriate.
Research and further studies on this
disease are essential and many populations generally have limited knowledge
about stroke and stroke risk factors. More tests should be used for ongoing
education and the general public's awareness in sub-Saharan Africa must be
assessed. In specific populations, stroke registries should be established.
This will provide a solid foundation for future statistical analysis and aid in
defining the heterogeneity of stroke.
7. Conclusion
In conclusion, despite advancements in our understanding of several essential elements of this disease, including its epidemiology, quality of life and pathophysiology, stroke continues to be a condition of significant public health concern. Ischemic stroke is currently the most prevalent stroke subtype in both developed and developing nations. Hypertension remains the leading risk factor for stroke in both industrialized and developing countries, despite racial differences in stroke risk factors. In order to avoid stroke, it is essential to identify these risk factors. Preventing long-term incapacity requires timely treatment, sufficient diagnostic tools and human resources. Supporting patients with stroke consequences also requires the provision of rehabilitation services.
8. References